Study: mRNA COVID vaccines cost-effective for US seniors, and under some scenarios, younger adults
Today in JAMA Network Open, University of Michigan-led research suggests that the US 2023-24 mRNA COVID-19 vaccines were cost-effective for people...
Today in JAMA Network Open, University of Michigan-led research suggests that the US 2023-24 mRNA COVID-19 vaccines were cost-effective for people...
Pediatric hospitals across the United States saw a surge in respiratory syncytial virus (RSV) in the summer of 2021 and...
Andrew Pekosz, PhD, professor and vice chair at Johns Hopkins University, said on X that while mRNA vaccine technology isn't perfect,...
Although many studies on air-cleaning technologies conclude that they prevent the indoor spread of respiratory viruses such as SARS-CoV-2 and...
Nearly 6 of 10 vaccine-eligible US children hospitalized for COVID-19 from 2022 to 2024 had at least one underlying medical...
In another change to how the Centers for Disease Control and Prevention (CDC) vaccine advisory group operates, the Department of...
COVID-19 survivors who experience social and economic hardship may be at higher risk for persistent symptoms, a Harvard Brigham and...
jmw120 / Flickr cc Yesterday in Morbidity and Mortality Weekly Report, investigators from the US Centers for Disease Control and Prevention...
USAID / Flickr cc Today in Open Forum Infectious Diseases, researchers from the Democratic Republic of the Congo (DRC) report that...
World Bank / Flickr cc At a time when federal officials are calling into question the safety and necessity of COVID-19...